Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?

The global roll-out of Xpert MTB/RIF (Cepheid Inc., Sunnyvale, CA, USA) has changed the diagnostic landscape of tuberculosis (TB). More than 16 million tests have been performed in 122 countries since 2011, and detection of multidrug-resistant TB has increased three- to eight-fold compared to conven...

Descripción completa

Detalles Bibliográficos
Autores principales: Albert, Heidi, Nathavitharana, Ruvandhi R., Isaacs, Chris, Pai, Madhukar, Denkinger, Claudia M., Boehme, Catharina C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2016
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967565/
https://www.ncbi.nlm.nih.gov/pubmed/27418550
http://dx.doi.org/10.1183/13993003.00543-2016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967565/
https://www.ncbi.nlm.nih.gov/pubmed/27418550
http://dx.doi.org/10.1183/13993003.00543-2016

Ejemplares similares